澳洲市場個股詳情
NSB Neuroscientific Biopharmaceuticals Ltd
- 0.036
- 0.0000.00%
延時20分鐘行情休市中 11/14 13:54 (悉尼)
520.58萬總市值18.00市盈率(靜)
0.000最高價0.000最低價0股成交量0.000今開0.036昨收0.00成交額0.07852周最高0.00%換手率1.45億總股本0.03352周最低0.002每股收益TTM373.14萬流通值0.540歷史最高18.00市盈率(靜)1.04億流通股0.033歷史最低0.002每股收益(静)0.00%振幅--股息TTM0.97市淨率1股每手--股息率TTM
Neuroscientific Biopharmaceuticals Ltd關鍵統計數據
季報+年報
顯示同比
| (FY)2024/06/30 | (FY)2023/06/30 | (FY)2022/06/30 | (FY)2021/06/30 | (FY)2020/06/30 | (FY)2019/06/30 | |
|---|---|---|---|---|---|---|
| 營業總收入 | ||||||
| 主營業務成本 | ||||||
| 毛利 | ||||||
| 營業費用 | -66.42%205.66萬 | -41.69%612.44萬 | 148.69%1,050.38萬 | 43.59%422.36萬 | 65.41%294.14萬 | 177.82萬 |
| 銷售和管理費用 | -27.15%128.62萬 | -35.40%176.55萬 | 73.58%273.3萬 | 36.66%157.45萬 | 96.96%115.21萬 | --58.49萬 |
| -管理費用 | -27.15%128.62萬 | -35.40%176.55萬 | 73.58%273.3萬 | 36.66%157.45萬 | 96.96%115.21萬 | --58.49萬 |
| 研發費用 | -87.77%49.25萬 | -44.24%402.61萬 | 225.53%722.01萬 | 55.89%221.79萬 | 94.78%142.27萬 | --73.04萬 |
| 折舊攤銷及損耗 | 57.87%9.13萬 | -10.88%5.79萬 | 5.71%6.49萬 | 8.38%6.14萬 | 2.64%5.67萬 | --5.52萬 |
| -折舊及攤銷 | 57.87%9.13萬 | -10.88%5.79萬 | 5.71%6.49萬 | 8.38%6.14萬 | 2.64%5.67萬 | --5.52萬 |
| 其他營業費用 | -32.14%18.65萬 | -43.41%27.49萬 | 31.35%48.57萬 | 19.32%36.98萬 | -23.97%30.99萬 | --40.76萬 |
| 營業利潤 | 66.42%-205.66萬 | 41.69%-612.44萬 | -148.69%-1,050.38萬 | -43.59%-422.36萬 | -65.41%-294.14萬 | -177.82萬 |
| 營業外利息收入與支出淨額 | 64.35%16.89萬 | 50.18%10.28萬 | 148.17%6.85萬 | -14.65%2.76萬 | -62.18%3.23萬 | 8.54萬 |
| 營業外利息收入 | 66.41%17.89萬 | 57.09%10.75萬 | 147.60%6.85萬 | -22.63%2.76萬 | -58.18%3.57萬 | --8.54萬 |
| 營業外利息支出 | 111.17%9,997 | --4,734 | ---- | -98.16%63 | --3,417 | ---- |
| 其他淨收入/費用 | -55.34%221.18萬 | 495.3萬 | 2,411.67%101.82萬 | 19.77%4.05萬 | 3.38萬 | |
| 其他營業外收入（費用） | -55.34%221.18萬 | --495.3萬 | ---- | 2,411.67%101.82萬 | 19.77%4.05萬 | --3.38萬 |
| 稅前利潤 | 130.34%32.42萬 | 89.76%-106.86萬 | -228.38%-1,043.53萬 | -10.78%-317.78萬 | -72.92%-286.85萬 | -165.89萬 |
| 所得稅 | 0 | 0 | 0 | 0 | 0 | 0 |
| 除稅後的權益收益 | ||||||
| 除稅後利潤 | 130.34%32.42萬 | 89.76%-106.86萬 | -228.38%-1,043.53萬 | -10.78%-317.78萬 | -72.92%-286.85萬 | -165.89萬 |
| 持續經營利潤 | 130.34%32.42萬 | 89.76%-106.86萬 | -228.38%-1,043.53萬 | -10.78%-317.78萬 | -72.92%-286.85萬 | ---165.89萬 |
| 歸屬於少數股東的淨利潤 | ||||||
| 歸屬於母公司的淨利潤 | 130.34%32.42萬 | 89.76%-106.86萬 | -228.38%-1,043.53萬 | -10.78%-317.78萬 | -72.92%-286.85萬 | -165.89萬 |
| 優先股派息 | ||||||
| 其他優先股派息 | ||||||
| 歸屬於普通股股東的淨利潤 | 130.34%32.42萬 | 89.76%-106.86萬 | -228.38%-1,043.53萬 | -10.78%-317.78萬 | -72.92%-286.85萬 | -165.89萬 |
| 基本每股收益 | 129.73%0.0022 | 89.82%-0.0074 | -227.48%-0.0727 | 39.51%-0.0222 | -58.19%-0.0367 | -0.0232 |
| 稀釋每股收益 | 129.73%0.0022 | 89.82%-0.0074 | -227.48%-0.0727 | 39.51%-0.0222 | -58.19%-0.0367 | -0.0232 |
| 每股派息 | ||||||
| 會計準則 | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
分析
目標價預測
暫無數據
熱議
澳大利亞
綜合熱度
股票代碼
最新價
升跌幅
暫無數據